Estrogen in a male body is not a leftover or a defect. It is a working hormone with specific jobs, and both too little and too much of it are linked with symptoms. The useful question is rarely whether estrogen is present, but whether it sits in sensible proportion to the androgens it came from.
Estradiol (E2) is the most potent form of estrogen in both sexes, reported from a blood sample in picograms per millilitre. The dedicated Estradiol guide covers how the test is run, which assays resolve the low concentrations seen in men, what the standard ranges are and how to read a single result, so this page stays on the biology.
One point is worth carrying forward. Male estradiol sits at a small fraction of typical female concentrations, which means the method used has to be sensitive enough to separate a modest value from a low one. A number on its own says very little. It becomes informative when it is read with androgen levels, binding proteins and whatever symptoms, if any, prompted the test in the first place.
Most of it is converted from testosterone. The enzyme aromatase, the product of the CYP19A1 gene, takes androgens and turns them into estrogens, converting testosterone into estradiol and the weaker androgen androstenedione into estrone. In women the ovary is the dominant production site. Men have no equivalent single organ, so production is spread across many tissues that make estradiol locally and release part of it into the circulation.
Research suggests that most of the estradiol circulating in a man's blood is produced outside the gonads, in peripheral tissues where aromatase acts on androgens delivered by the bloodstream 1. Aromatase activity has been described in adipose tissue, bone, brain, skin, blood vessels, liver and inside the testis itself, where both Leydig and Sertoli cells contribute 2.
That local production matters more than the blood number sometimes suggests. Estradiol made inside bone or brain tissue largely acts where it is made, so concentrations at the receptor can be higher than anything a venous sample shows. The blood value is a useful proxy, not a complete map.
Two practical consequences follow. First, a man's estradiol is downstream of his androgen supply, so anything that changes testosterone production tends to move estradiol with it. Second, body composition is part of the equation, because adipose tissue carries meaningful aromatase capacity. Two men with identical testosterone can carry quite different estradiol simply because one has more conversion capacity than the other.
It acts on bone, brain, fat tissue, blood vessels and the reproductive tract, through estrogen receptors found throughout male tissue. The idea that estradiol is a passive by-product of testosterone metabolism has not survived the last few decades of work on estrogen receptors and aromatase in men 2.
The clearest roles described in the literature include the following.
None of this makes estradiol more important than testosterone in men. It makes the two inseparable. Much of what testosterone appears to do in a male body depends on a share of it being converted to estradiol first 3.
Because estrogen, more than testosterone, is the hormone that restrains bone breakdown in men. Bone is constantly remodelled, with osteoclasts removing old tissue and osteoblasts laying down new. Estradiol acts on both sides of that cycle, slowing resorption and supporting the survival of bone-forming cells.
Studies indicate that deficiency of estrogen signalling, as well as androgen deficiency, drives the cellular changes behind primary osteoporosis, through effects on osteoclast activity and bone remodelling balance 4. In men, estradiol is considered important for bone growth and the maintenance of skeletal health 3.
The most striking evidence comes from rare inherited conditions 5. In men with aromatase deficiency, who cannot convert androgens to estrogens, and in the described case of estrogen receptor insensitivity, growth plates fail to close normally, stature continues to increase into adulthood and bone density is low despite normal or high testosterone 5. Those cases separated the two hormones, and they pointed clearly at estradiol as the signal that finishes the skeleton and then maintains it.
For a man reading his own panel, the practical takeaway is modest but real. Persistently low estradiol, particularly alongside low testosterone, is one of the findings a clinician may weigh when considering bone health, and bone density is assessed by imaging rather than by a hormone value.
Male estradiol runs roughly an order of magnitude lower than the levels seen across a menstrual cycle, which is why the comparison is often misread as an absence. The table below puts typical lab reference ranges next to FitScript's optimal ranges.
| Group | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Estradiol, men | 10 to 40 pg/mL | 20 to 35 pg/mL |
| Estradiol, women | 15 to 500 pg/mL | 30 to 400 pg/mL |
Reference ranges vary by laboratory, assay method, age and sex, and the female range in particular shifts substantially across the menstrual cycle and after menopause, so always read a result against the range printed on your own report. FitScript's optimal ranges are optimization targets rather than diagnostic cut-offs, and a value outside them is a prompt for conversation, not a conclusion.
Notice how narrow the male window is in absolute terms. A shift of ten or fifteen picograms per millilitre can move a man from the middle of the range to one edge of it, which is exactly why assay sensitivity and consistent testing conditions matter more here than they do for a woman of reproductive age.
Anything that increases aromatase capacity, increases the supply of androgen substrate or slows clearance. The common contributors are reasonably well described.
Body fat. Adipose tissue is a significant site of aromatase activity, so greater fat mass generally means greater conversion of androgens to estrogens 1. This is one of the more modifiable inputs on the list.
Alcohol and liver function. The liver clears steroid hormones and makes the binding proteins that carry them. Regular heavy alcohol intake is associated with changes in the androgen to estrogen balance in men, and reduced hepatic function can slow hormone clearance.
Exogenous testosterone. Taking testosterone raises the substrate available to aromatase, so estradiol commonly rises along with it. That is physiology, not a side effect to be feared, but it is one of the reasons a licensed provider evaluates whether testosterone therapy is appropriate for a given person and monitors the full hormone picture during it. This page gives no amounts, schedules or administration guidance for any prescription therapy.
Medications. Several drug classes influence estrogen levels or estrogen signalling, including some used in cardiology, psychiatry and oncology, as well as human chorionic gonadotropin. Bring a full medication and supplement list to any discussion about hormone results, because a licensed provider is the person who can judge whether a medication is contributing.
Age and insulin resistance. Rising fat mass, rising binding globulin and falling testicular output all shift the ratio between the two hormones as men get older.
Uncommon causes. Rarely, hormone-producing tumours of the testis or adrenal gland raise estrogen substantially. A markedly elevated estradiol, particularly with breast tissue changes or testicular findings, is worth discussing with a clinician promptly rather than monitoring at home.
Loss of substrate, loss of enzyme activity or loss of overall energy availability. Because male estradiol is manufactured from testosterone, almost anything that lowers testosterone lowers estradiol with it.
Very low body fat is the other common route, particularly in athletes combining heavy training loads with restricted intake. Low energy availability suppresses the reproductive axis, and the reduced fat mass also reduces peripheral conversion capacity. The combination can take estradiol below the typical range even in a young, apparently healthy man.
Medications that block aromatase lower estradiol by design, and that effect is the point of their clinical use. When estradiol falls too far in men, the reported consequences include joint discomfort, reduced libido, mood changes and, over time, loss of bone density 3. Whether any such medication is appropriate, and at what intensity, is a decision only a licensed provider can make after reviewing the person in front of them.
Finally, the rare congenital conditions mentioned earlier, aromatase deficiency and estrogen receptor insensitivity, represent the extreme end of this spectrum and are usually identified through growth, skeletal and fertility findings rather than through routine panels 5.
The ratio shifts more reliably than the absolute number. Across adult life, total testosterone tends to decline gradually while sex hormone binding globulin tends to rise, which reduces free testosterone more steeply than total. Estradiol, supported by aromatase activity in a typically larger fat mass, is relatively better preserved, so the balance between the two moves in the estrogenic direction even when estradiol itself has barely changed.
Research on estradiol in older men suggests that circulating estradiol does not fall in parallel with testosterone, and that estrogen status in later life carries relevance for bone and other tissues 6. That is one reason a single estradiol value interpreted without an age context, a body composition context and a testosterone value alongside it can be misleading.
It is also why the popular framing of ageing in men as simply low testosterone is incomplete. Two men of the same age with the same total testosterone may have quite different free androgen availability and quite different estradiol, and those differences show up in symptoms rather than in the headline number.
Because estradiol is a product of testosterone, and because the same binding protein controls how much of each hormone is free to act. Interpreting one in isolation discards most of the information.
Sex hormone binding globulin binds testosterone with high affinity and estradiol with somewhat lower affinity, and albumin binds both more loosely. Only the unbound fraction, plus the loosely albumin-bound portion, is generally considered available to tissue. A man with high binding globulin can show a reassuring total testosterone while carrying far less free hormone, which changes how his estradiol value should be read. A man with low binding globulin shows the reverse pattern.
This is why clinicians often look at the relationship between the two hormones rather than at either value alone. A testosterone in the lower part of the range with an estradiol in the upper part tells a different story from the same estradiol sitting beneath a robust testosterone. Neither pattern is a diagnosis. Both are observations that can be matched against symptoms, body composition, medications and the rest of the panel.
The sequence worth keeping in mind is simple. What does the value show, what might it reflect given everything else on the report, and what is worth raising with a clinician. Skipping the middle step is how a single out-of-range number turns into an unnecessary worry or an unnecessary intervention.
Symptoms at both ends overlap heavily, which is the main reason they cannot be used to guess a number. When estradiol runs high relative to androgens, the commonly reported features include breast tenderness or enlargement of breast tissue, fluid retention, reduced libido, erectile difficulty, low mood and poorer recovery from training. When it runs low, men commonly report joint aches, reduced libido, low mood, poor sleep, hot flushes and, over the longer term, reduced bone density.
Low libido and erectile difficulty appear on both lists. So does low mood.
That overlap also means self-directed attempts to push the number in one direction, based on symptoms alone, are a poor idea. In men with new breast tissue changes, persistent sexual dysfunction, fertility difficulty or unexplained fractures, the right move is a proper evaluation that looks at hormones, medications, liver and thyroid function and clinical examination together. This page is educational and not medical advice.
Yes, in small amounts. Progesterone is produced in the adrenal cortex and the testes, and it sits upstream in the steroid pathway as a precursor to androgens, cortisol and aldosterone. Male circulating levels are a fraction of those seen in a woman's luteal phase.
Beyond its role as a precursor, progesterone receptors are present in male tissue, including the brain and reproductive tract, and progesterone and its metabolites have described actions in the nervous system. The clinical significance of a routine progesterone measurement in men is far less established than that of testosterone or estradiol, and it is not a standard part of most male hormone workups.
The broader point is that the labelling of steroids as male or female hormones is a historical convenience rather than a biological fact 8. Both sexes make the full set. What differs is the quantity, the dominant production site and the tissue context in which each one acts.
Partly by accident, and partly through rare patients. Estrogen was first isolated in quantity from an unlikely source, and early work found high estrogen concentrations in the urine of stallions, which complicated the tidy assumption that estrogens were exclusively female 7. For decades afterwards, estrogen in men was treated largely as a curiosity.
The reframing came later, from three directions. Animal models lacking aromatase or estrogen receptors showed reproductive, skeletal and metabolic abnormalities in males. Human case reports of aromatase deficiency and estrogen receptor insensitivity showed unfused growth plates, continued growth and low bone density in men with normal androgens 5. And detailed mapping of aromatase and estrogen receptor distribution found both throughout male tissue, including the testis itself 8.
By the time those strands were drawn together, the field had moved from asking whether men have estrogen to asking how much they need and where 7. That is still the open question, and it is why optimal targets in men are framed as narrower, more cautious windows than the broad ranges a laboratory prints.
They can influence the inputs, which is not the same as setting the number directly. The levers with the clearest mechanistic basis are body composition, alcohol intake, sleep and overall energy balance.
In men, plasma estradiol is strongly and positively related to body fat mass, particularly subcutaneous abdominal fat 6, which makes excess fat mass the most direct non-pharmacological influence on estradiol in men who carry significant adiposity. Resistance training and adequate protein support the retention of lean mass while fat mass comes down, which matters because losing weight quickly while losing muscle tends to leave the hormonal picture no better.
Alcohol is the second lever. Heavy intake affects both the liver's handling of steroid hormones and testicular function, so reducing it changes two parts of the system at once. Sleep is the third, since testosterone production follows a circadian pattern that is sensitive to short or fragmented sleep, and estradiol follows its substrate.
What these changes will not do is produce a predictable target value. The response varies between individuals, and expecting a specific number from a specific behaviour sets up disappointment. The reasonable expectation is a better overall hormonal context, with the number as feedback rather than as the goal. Over-the-counter products marketed as estrogen blockers for men are not a substitute for identifying why a value is where it is, and any decision about a prescription approach belongs to a licensed provider.
The ones that explain where estradiol came from and what is carrying it. A standalone estradiol in a man generates more questions than answers, so it is usually ordered within a panel.
FitScript's membership covers 150+ biomarkers tested per year, with Atlas, the AI health advisor, reading each result in the context of the rest of the panel rather than as an isolated line on a report, and with a licensed provider deciding on anything that requires a prescription.
Whenever a value sits outside the range, when symptoms are persistent, or when both are true at once. Specific situations deserve a prompt conversation rather than a wait-and-see approach. New or growing breast tissue, breast tenderness or a lump, testicular pain, swelling or a change in size, markedly elevated estradiol, unexplained fractures or loss of height, and infertility are all findings to discuss with a clinician promptly.
For less urgent patterns, a borderline value alongside vague fatigue for example, the useful preparation is context. Bring the full result including the laboratory's own reference range, the time of day the sample was drawn, a list of all medications and supplements, any history of anabolic steroid or testosterone use, alcohol intake and recent changes in weight or training. Repeating the test under consistent conditions before drawing conclusions is often reasonable, and a clinician can advise whether that applies.
Discuss any result or proposed treatment with a clinician or licensed provider before acting on it. An out-of-range number is information, not a verdict, and the interpretation depends on the whole person rather than the line it appeared on.
If you want to go deeper on the two markers this page keeps pointing at, the testosterone guide explains what total testosterone measures and why it moves through the day and across the years, and the SHBG guide covers the binding protein that decides how much of each hormone is free to reach tissue.
It is entirely normal. Every man produces estradiol, mostly by converting testosterone through the enzyme aromatase in fat, bone, brain and testicular tissue. Estrogen receptors are present throughout male tissue. The question clinicians ask is not whether estrogen is there, but whether it sits in sensible proportion to testosterone and the symptoms a man reports.
Roughly an order of magnitude less. Typical lab reference ranges for men sit around 10 to 40 pg/mL, while female ranges span roughly 15 to 500 pg/mL and shift substantially across the menstrual cycle. Ranges vary by laboratory, assay, age and sex, so read any result against the range printed on your own report.
Reported features of low estradiol in men include joint discomfort, reduced libido, low mood, poor sleep, hot flushes and, over time, reduced bone density. Estradiol is the main hormonal brake on bone breakdown in men, which is why a persistently low value alongside low testosterone is worth discussing with a clinician rather than ignoring.
Adipose tissue carries meaningful aromatase activity, so greater fat mass generally increases the conversion of androgens into estrogens. That is why two men with identical testosterone can show quite different estradiol values. Reducing excess fat mass while retaining lean tissue is the most direct non-pharmacological influence on this conversion, though individual responses vary.
Because estradiol is made from testosterone, and sex hormone binding globulin controls how much of both hormones is free to act on tissue. A total testosterone can look reassuring while free hormone is low, which changes how the estradiol value reads. Interpreted alone, a single estradiol number discards most of the useful information.
Yes, in small amounts, from the adrenal cortex and the testes. It functions mainly as a precursor in the pathway leading to androgens, cortisol and aldosterone, and progesterone receptors are present in male tissue including the brain. Routine progesterone testing is not a standard part of most male hormone workups.
Not reliably. Reduced libido, erectile difficulty and low mood appear at both ends of the range, because estrogen signalling in men behaves more like a window than a straight line. That overlap is the main argument for measuring rather than guessing, and for interpreting the result alongside testosterone, medications and clinical findings.
Promptly in the case of new or growing breast tissue, breast tenderness or a lump, testicular pain or swelling, markedly elevated estradiol, unexplained fractures or fertility difficulty. For borderline values with vague symptoms, bring the full report, the laboratory reference range, sampling time and a complete medication and supplement list to the conversation.